Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?

Literature DB >> 28623419

Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?

Horacio Kaufmann¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2017 PMID： 28623419 DOI： 10.1007/s10286-017-0426-6

Source DB: PubMed Journal: Clin Auton Res ISSN： 0959-9851 Impact factor: 4.435

× No keyword cloud information.

9 in total

1. The decarboxylation of -3: 4-dihydroxyphenylserine (noradrenaline carboxylic acid).

Authors: H BLASCHKO; P HOLTON; G H S STANLEY
Journal: Br J Pharmacol Chemother Date: 1948-12

2. The formation of noradrenaline from dihydroxyphenylserine.

Authors: H BLASCHKO; J H BURN; H LANGEMANN
Journal: Br J Pharmacol Chemother Date: 1950-09

3. Enzymic formation of noradrenaline in mammalian tissue extracts.

Authors: K H BEYER; H BLASCHKO; J H BURN; H LANGEMANN
Journal: Nature Date: 1950-06-10 Impact factor: 49.962

4. The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale.

Authors: Horacio Kaufmann; Richard Malamut; Lucy Norcliffe-Kaufmann; Kathleen Rosa; Roy Freeman
Journal: Clin Auton Res Date: 2011-11-02 Impact factor: 4.435

5. Droxidopa in neurogenic orthostatic hypotension.

Authors: Horacio Kaufmann; Lucy Norcliffe-Kaufmann; Jose-Alberto Palma
Journal: Expert Rev Cardiovasc Ther Date: 2015-06-19

Review 6. Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension.

Authors: Ahmed Elgebaly; Bassant Abdelazeim; Omar Mattar; Mohamed Gadelkarim; Rehab Salah; Ahmed Negida
Journal: Clin Auton Res Date: 2016-03-07 Impact factor: 4.435

7. Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxyphenylserine.

Authors: T Suzuki; S Higa; S Sakoda; A Hayashi; Y Yamamura; Y Takaba; A Nakajima
Journal: Neurology Date: 1981-10 Impact factor: 9.910

8. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome.

Authors: T Kachi; S Iwase; T Mano; M Saito; M Kunimoto; I Sobue
Journal: Neurology Date: 1988-07 Impact factor: 9.910

9. Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension.

Authors: Italo Biaggioni; L Arthur Hewitt; Gerald J Rowse; Horacio Kaufmann
Journal: BMC Neurol Date: 2017-05-12 Impact factor: 2.474

9 in total

1. Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension.

Authors: Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Jose Martinez; Horacio Kaufmann
Journal: Neurology Date: 2018-09-19 Impact factor: 9.910

2. Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges.

Authors: Jose-Alberto Palma; Horacio Kaufmann
Journal: Semin Neurol Date: 2020-09-09 Impact factor: 3.420

Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?

1. The decarboxylation of -3: 4-dihydroxyphenylserine (noradrenaline carboxylic acid).

2. The formation of noradrenaline from dihydroxyphenylserine.

3. Enzymic formation of noradrenaline in mammalian tissue extracts.

4. The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale.

5. Droxidopa in neurogenic orthostatic hypotension.

Review 6. Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension.

7. Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxyphenylserine.

8. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome.

9. Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension.

1. Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension.

2. Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges.

Review 3. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.

Review 4. Management of Orthostatic Hypotension.

Review 5. Orthostatic Hypotension in Parkinson Disease.

Review 6. Autonomic Dysfunction in Parkinson's Disease.

Review 7. An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy.

8. Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.

Review 9. A Comprehensive Review of Neuronal Changes in Diabetics.